(Q33617948)

English

Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

retinopathy of prematurity

1 reference

based on heuristic

inferred from title

photobiomodulation

0 references

Khalil Ghasemi Falavarjani

4

object named as

Khalil Ghasemi Falavarjani

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Hossein Nazari

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Mehdi Modarres

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Mohammad Mehdi Parvaresh

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

27 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

248

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1713-1718

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1430-X

21 January 2018

Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concern

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The International Classification of Retinopathy of Prematurity revisited

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early vitreous surgery for aggressive posterior retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk for retinal detachment associated with hemorrhages pre- and postlaser treatment in retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transscleral diode laser retinal photocoagulation for the treatment of threshold retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involution of retinopathy of prematurity after laser treatment: factors associated with development of retinal detachment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitreous hemorrhage in patients with high-risk retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antivascular endothelial growth factor for retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-port lens-sparing vitrectomy for aggressive posterior retinopathy of prematurity: early surgery before tractional retinal detachment appearance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20582706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00417-010-1430-X

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33617948&oldid=2195574288"